Mahaflox Eye Drop contains Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of bacterial infections of the eye. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination, thereby preventing bacterial cell proliferation. Mahaflox Eye Drop is primarily prescribed for bacterial conjunctivitis and other superficial ocular infections caused by susceptible strains of Gram-positive and Gram-negative bacteria. The formulation ensures rapid penetration into ocular tissues, providing effective eradication of pathogens with minimal systemic absorption. It is typically administered as one or two drops into the affected eye(s) every 12 hours or as directed by a healthcare professional. Patients should be advised to avoid contamination of the dropper tip and to complete the full course of therapy even if symptoms improve. Common side effects may include transient eye irritation, burning sensation, or redness. Use with caution in patients with known hypersensitivity to fluoroquinolones. Mahaflox Eye Drop offers a potent and convenient option for managing bacterial ocular infections, promoting faster resolution and reducing the risk of complications.